Reaction
Eye Allergy reporting signals
As of the last recalculation, Eye Allergy appears in 1,518 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is TRAVOPROST (PRR 51.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Travoprost | 32 | 51.8 | 52.0 |
| Brinzolamide | 19 | 30.4 | 30.4 |
| Brimonidine Tartrate | 37 | 29.2 | 29.2 |
| Ciclesonide | 21 | 21.4 | 21.5 |
| Dorzolamide Hydrochloride And Timolol Maleate | 11 | 19.2 | 19.2 |
| Bimatoprost | 38 | 18.5 | 18.5 |
| Latanoprost | 58 | 16.4 | 16.4 |
| Timolol | 14 | 16.0 | 16.0 |
| Clobetasol Propionate Ointment Usp, 0.05% | 11 | 14.7 | 14.8 |
| Clobetasol Propionate | 11 | 14.7 | 14.7 |
| Fexofenadine Hcl | 8 | 11.9 | 11.9 |
| Timolol Maleate | 8 | 11.1 | 11.1 |
| Lifitegrast | 13 | 11.0 | 11.0 |
| Dupilumab | 286 | 9.8 | 9.8 |
| Ribociclib | 18 | 7.9 | 7.9 |
| Omalizumab | 46 | 7.6 | 7.6 |
| Carboxymethylcellulose Sodium | 5 | 7.3 | 7.3 |
| Avapritinib | 6 | 6.8 | 6.8 |
| Fexofenadine Hydrochloride | 10 | 6.3 | 6.3 |
| Ranibizumab | 10 | 5.2 | 5.2 |
| Loratadine And Pseudoephedrine Sulfate | 3 | 5.2 | 5.2 |
| Pseudoephedrine Hydrochloride | 3 | 4.0 | 4.0 |
| Pseudoephedrine Hcl | 3 | 3.7 | 3.7 |
| Aflibercept | 8 | 3.5 | 3.5 |
| Adapalene | 11 | 0.8 | 0.8 |